ETFIQData as of Nov 18, 2026. · etfiq.com/funds/medi

MEDI Fact Sheet: Harbor Health Care ETF

Share
$34.93
close, Nov 18, 2026

Over the year to Nov 18, 2026, MEDI returned +10.4% in total and charged 0.80% a year.

1-year total return
+10.4%
to Nov 18, 2026
Expense ratio
0.80%
a year
Net assets
$42m
on Nov 16, 2026
Net flow, last 3 trading days
−$1.8m
daily basis to Nov 16, 2026

Growth of $10,000, 1 year

MEDI $11,040 +10.4% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+7.2%
3 months−1.9%
Year to date+11.1%
1 year+10.4%
3 years+60.0%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Eli Lilly & Co20.78%
Ascendis Pharma A/S13.61%
Gilead Sciences Inc5.10%
Rhythm Pharmaceuticals Inc4.02%
AbbVie Inc3.09%
Intuitive Surgical Inc2.83%
Cencora Inc2.75%
Revolution Medicines Inc2.54%
Insmed Inc2.52%
Merck & Co Inc2.47%

MEDI top ten by weight, 59.7% of the fund, of its 44 equity positions, from the holdings filed for Jul 31, 2026.

Facts

Equity fund · Actively managed · First traded Nov 17, 2022 · Benchmark Its own holdings, as of Jul 31, 2026; its prospectus names no index it tracks

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, MEDI Fact Sheet: Harbor Health Care ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/medi/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/medi.